Position in REGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$122,010,565
-$22,000,259 QoQ
Shares Held
195,674
+5.0% QoQ
Ownership
0.190%
of shares outstanding
% of Portfolio
0.55%
of 13F equity value
Holder Rank
#67
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Candriam S.C.A. holds $2,107,868,027 across 75 Biotechnology names. REGN ranks #1 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
195,674 | $122,010,565 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
556,392 | $104,201,093 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
199,505 | $99,100,118 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
314,512 | $94,677,547 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
289,735 | $82,565,782 | |
| 6 | COGT |
Cogent Biosciences, Inc.
|
2,088,369 | $80,819,880 | |
| 7 | ARGX |
Argenx SE
|
80,120 | $74,332,932 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,990,510 | $70,444,148 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $122,010,565 | 195,674 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $144,010,824 | 186,388 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $158,489,610 | 205,332 | Shares | Sole | 2026-04-30 | |
| 2025-09-30 | $95,301,953 | 169,495 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $74,659,200 | 142,208 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $136,322,029 | 214,941 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $186,272,869 | 261,498 | Shares | Other | 2025-02-07 | |
| 2024-09-30 | $265,464,381 | 252,525 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $210,950,129 | 200,708 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $209,602,409 | 217,771 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $212,210,673 | 241,618 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $238,913,516 | 290,310 | Shares | Other | 2023-11-13 | |
| 2023-06-30 | $219,598,756 | 305,618 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $286,752,969 | 348,988 | Shares | Other | 2023-05-12 | |
| 2022-12-31 | $276,307,581 | 382,968 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $277,284,641 | 402,521 | Shares | Other | 2022-11-10 | |
| 2022-06-30 | $220,369,125 | 372,793 | Shares | Other | 2022-08-03 | |
| 2022-03-31 | $257,919,521 | 369,290 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $230,243,350 | 364,586 | Shares | Other | 2022-02-10 | |
| 2021-09-30 | $235,198,970 | 388,643 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $296,219,454 | 530,346 | Shares | Other | 2021-07-20 | |
| 2021-03-31 | $190,978,702 | 403,641 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $195,001,070 | 403,637 | Shares | Other | 2021-01-22 | |
| 2020-09-30 | $180,829,091 | 323,036 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $142,754,107 | 228,901 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $200,792,660 | 411,216 | Shares | Sole | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||